Safety &Efficacy of CF101 to Subjects With Uveitis

Summary

This is a Phase 2, randomized, double-masked, placebo-controlled study subjects with active, sight-threatening, noninfectious intermediate or posterior uveitis.

Timeline

Start

2019-01

Primary completion

2019-09

Completion

2019-10

Outcome

Outcome not reported

Stopped: “The company has decided not to conduct the study”

Drugs

Indications